Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2012

View Archived Issues

Allergan divulges new S1P1 receptor ligands

Scientists at Exelixis design novel inhibitors of protein kinases

Mavoglurant studies reported at various conferences

CC-223 well tolerated in early-stage clinical study

Promising first-in-human results disclosed for CH-5132799

New Acceleron Pharma drug reduces anemia in model of myelodysplastic syndromes

New levodopa prodrugs presented by Ono Pharmaceutical

New acetyl-CoA carboxylase inhibitors prepared in Japan

Bispecific tetravalent cancer immunotherapic is efficacious and safe in vivo

Sirnaomics awarded NIH grant for siRNA therapeutic

PPI-668 shows promise in patients with HCV infection

Nissan Chemical Industry reports novel anticancer agents

Researchers at Esteve synthesize new agents for pain

Dosing begins in RXI-109 dermal scarring study

Roche decides against exercising opt-in rights to Biotie drug

FDA sets PDUFA date for Heplisav BLA

CHMP issues opinion on subcutaneous use of Velcade

Preclinical development of leishmaniasis vaccine complete

Medivir and Swedish University of Agricultural Sciences launch collaboration

Cellceutix set to kick off phase I trial of Kevetrin

Fuji Film Pharma acquires Japanese marketing rights for three products from Bayer Yakuhin

Astellas Pharma submits MAA for enzalutamide

NICE recommends new treatment options for prostate and lung cancer

Novel S1P4 receptor ligands disclosed

BioSpecifics Technologies commences phase II Xiaflex trial

New NanoTherm research agreement initiated

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...